Alkixen 250 mg (Crizotinib) is a targeted tyrosine kinase inhibitor used to treat ALK-positive or ROS1-positive non-small cell lung cancer. It helps slow cancer growth by blocking abnormal proteins. Common side effects include nausea, diarrhea, vision changes, and swelling. Use under medical supervision. https://oncomedicure.com/product/alkixen-250-mg-crizotinib/